[Cl:1]N1C2C=CC=CC=2N=N1.[F:11][C:12]([F:29])([F:28])[C:13]1[CH:18]=[CH:17][CH:16]=[C:15]([C:19]2[N:24]3[N:25]=[CH:26][CH:27]=[C:23]3[N:22]=[CH:21][CH:20]=2)[CH:14]=1.C(Cl)(Cl)Cl.[OH-].[Na+]>C(Cl)Cl>[Cl:1][C:27]1[CH:26]=[N:25][N:24]2[C:19]([C:15]3[CH:14]=[C:13]([C:12]([F:28])([F:11])[F:29])[CH:18]=[CH:17][CH:16]=3)=[CH:20][CH:21]=[N:22][C:23]=12A 3.3 g. portion of N-chlorobenzotriazole is added to a solution of 5.26 g. of 7-(α,α,α-trifluoro-m-tolyl)pyrazolo[1,5-a]pyrimidine in 50 ml. of chloroform producing an exothermic reaction. The mixture is refluxed on a steam bath for 15 minutes, cooled to room temperature and then poured into an ice-cold solution of 2.5 N sodium hydroxide. The organic layer is separated, dried over socium sulfate and passed through a hydrous magnesium silicate column. The effluent is heated to reflux and hexane is added giving a solid. The solid is dissolved in methylene chloride re-processed through the column and precipitated from refluxing solution with hexane giving crystals of the desired product, m.p. 155°-157° C.